Hyderabad, May 6: Dr Reddy’s Laboratories Limited on Monday announced the launch of Testosterone Gel 1.62 per cent, a therapeutic equivalent generic version of AndroGel in US market.
It was approved by the U.S. Food and Drug Administration (USFDA), Hyderabad-based pharmaceutical company said in a release here.
The AndroGel (testosterone gel) brand and generic had U.S. sales of approximately $815.6 million MAT for the most recent 12months ending in February 2019 according to IQVIA Health.
Dr. Reddy’s Testosterone Gel is available in a net quantity of 88 g pump which dispenses 20.25 mg of testosterone per actuation.
Each metered-dose pump is capable of dispensing 60 metered pump actuations, the release added. (UNI)